Search Results

Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive course library covering cutting-edge GPCR science ✅ Practical insights for real-world drug discovery Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

🔬🧪 Molecular glues offer a new way to fine-tune receptor signaling, opening doors for next-gen drug GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com /reviews/molecular-glues%3A-a-new-approach-to-modulating-gpcr-signaling-bias #gpcr #drgpcr Published on February 17, 2025 Category GPCR Weekly News Game-changer for GPCR research! 🔬🧪 Molecular glues offer a new way to fine-tune receptor signaling, opening doors for next-gen drug

GPCR Happy Hour – Connect, Collaborate, Discover A global networking event where GPCR scientists break Scientist-led : Built by GPCR researchers, for GPCR researchers. Action-oriented : Conversations designed to spark collaborations, not just chatter. How It Works? welcomes the global biotech and drug discovery community. GPCR Happy Hour Dr. GPCR News Aug 20, 2025 3 min read

Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug David has over 20+ years of experience working in a drug discovery environment mainly in a specialist 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology and Drug current interests include the development of HTS fluorescence-based kinetic binding assays specifically designed GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

Home → Flash News → Class B GPCR drugs are reshaping treatment for migraine, diabetes, and obesity- but This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #drgpcr Published on June 2, 2025 Category GPCR Weekly News Class B GPCR drugs are reshaping treatment This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock

Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs of GPCR Ligands as Therapeutic Drugs,” with Dr. Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

Explore their innovative GPCR projects, collaborations, and contributions to cutting-edge drug discovery innovative fluorescent probes that de-risk the pre-clinical drug discovery phase. dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug Custom Development Tailored fluorescent probes designed for unique research requirements.

and drug discovery innovation. << Back to podcast list Strategic Partner(s) From Curiosity to Breakthrough : Ajay Yekkirala on GPCR Innovation What if the key to safer, more effective drugs lies in asking the drug developer and entrepreneur. Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. led Ajay Yekkirala to reshape the future of GPCR-targeted medicine. Enjoying the Dr. GPCR Podcast?

GPCR Ecosystem We unite the GPCR Community to advance drug discovery Where GPCR Experts Move Science Forward Join the global community accelerating GPCR drug discovery through trusted insights, expert tools We designed the Ecosystem to support your work —no matter where you are in your GPCR journey. behind-the-scenes tools and insight What Makes the Ecosystem Different Built for Drug Discovery Designed by scientists in the GPCR space to accelerate your research goals Collaborative by Design Connects researchers

Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Ecosystem , a space designed to break silos, spark collaboration, and open real dialogue across Featured Appearances Aug 2020 — Featured on 17 Minutes of Science with Advancing GPCR Drug Discovery Mar 2022 — Media Partner at GPCR Targeted Drug Discovery Summit . Feb 2023 — Media Partner at GPCR Targeted Drug Discovery Summit . Community Engagement Mar 2024 — Media Partner at 3rd GPCR Targeted Drug Discovery Summit .

genetic variants impact obesity-linked signaling pathways and highlights new opportunities for precision drug GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️ https://www.ecosystem.drgpcr.com #gpcr#drgpcr Published on May 5, 2025 Category GPCR Weekly News A high-resolution deep mutational scan genetic variants impact obesity-linked signaling pathways and highlights new opportunities for precision drug uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

“Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs GPCR Courses 🔥 New Course Alert! “Development of GPCR Ligands as Therapeutic Drugs” with Dr. 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

Applying Pharmacology to Drug Discovery by Terry Kenakin | Dr. GPCR Courses Applying Pharmacology to Drug Discovery Dr. GPCR and the offered resources in my work sphere Anonymous Dr. GPCR the best for the sake of promoting more educational opportunities that are sorely needed in the challenges we encounter in our work Anonymous The best pharmacology teacher teaming up with the best GPCR

Learn from leading GPCR experts — anytime, anywhere Access trusted, on-demand courses designed to help networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed for researchers At Dr.GPCR University, you’ll find: Courses: Dive deep into curated educational content designed by experts GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as

Sokhom Pin shares how he built a biotech career around GPCRs, designed a custom PhD path, and led teams Designing a Non-Traditional PhD While working full-time, Sokhom architected a one-of-a-kind PhD program GPCR ecosystem , GPCR scientist network , GPCR drug discovery , GPCR training program , GPCR online course by AI ________ About Sokhom Pin Sokhom Pin is a receptor pharmacologist with over 20 years of drug discovery He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general

self-sustaining computational chemistry service provider, developing its own software for application in various drug I have extensive training in computer-aided drug design. training as a chemist and as an entrepreneur to grow a sustainable service and software provider in drug GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks

Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

and lateral gateways, unlocking new possibilities for drug discovery. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #gpcr#drgpcr Published on March 17, 2025 Category GPCR Weekly News A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric sites and lateral gateways, unlocking new possibilities for drug uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. the GPCR G protein subtype selectivity? GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. ➡ https:// www.ecosystem.drgpcr.com /gpcr-binders-drugs-and-more/design-of-allosteric-modulators-that-change-gpcr-g-protein-subtype-selectivity #gpcr #drgpcr Previous Next Recent Articles

Emmanouil Kyrloglou on the web Adhesion GPCR Consortium LinkedIn A single cell GPCR map of thermogenic , located within the GPCR autoproteolysis inducing (GAIN) domain. This research focuses on the design of a new endogenous ADGRB1 activation reporter assay to test analogs University" About Jesse Stillwell "Jesse Stillwell is a 3rd year graduate student with a research focus in drug His project is drug discovery focused, with particular interest in use of a novel epigenetic therapy

GPCR to expand fluorescent ligand tools for GPCR drug discovery, connecting biotech startups and scientists Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. GPCR Courses ⚠️ Registration Deadline today! Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. ✳️ Last chance https://www.ecosystem.drgpcr.com/advanced-methods-for-the-optimization-of-candidate-selection #gpcr #

Stay current in drug discovery with the University Vault. Quickly get up to speed on new GPCR targets and mechanisms, and gain a competitive edge with our extensive University Vault: The Ultimate On-Demand GPCR Learning Library Every talk inside the University Vault field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather Anonymous This looks super useful for drug discovery!

Curious about how these advances could impact drug discovery? Check out the latest review on GPCR biosensors. Curious about how these advances could impact drug discovery? ➡️ https:// www.ecosystem.drgpcr.com/reviews/gpcr-biosensors-to-study-conformational-dynamics-and-signaling-in-drug-discovery uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design

for plate readers, specifically designed to study internalization using time-resolved fluorescence ( View Reagents Explore Revvity’s GPCR Assay Technologies Tools designed to illuminate every step of GPCR GPCR Spotlights Revvity’s pHSense™ Reagents for Real-Time GPCR Internalization A new reagent family designed GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud A Tool Designed for Real Research Needs Built on more than two decades of GPCR assay innovation, pHSense

Can models predict drug outcomes? Jens Carlsson shares how GPCR modeling is moving from explanation to real prediction in drug discovery With a deep focus on structure-based drug design, Jens discusses how his lab bridges simulation and experiment—and Outside academia, he advises companies through a consulting arm focused on ligand design strategy. GPCR Podcast? Leave a Review.

As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and adhesion GPCRs. GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs), that control virtually everything in the body, as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the

GPCR podcast episode. If you’re passionate about GPCRs and drug discovery, this episode is a must-listen! GPCR Podcast Behind every great discovery is a great question 🚀 Dr. GPCR podcast episode. If you’re passionate about GPCRs and drug discovery, this episode is a must-listen!

GPCR Ecosystem. List your services and your brand on the world's first GPCR CRO Bank. The GPCR CRO Bank is a marketing-first offering designed to help service providers and tool companies GPCR is the world's largest nonprofit community focused on GPCRs. As a CRO partner, you'll gain trusted access to an engaged audience of biotech teams and drug discovery GPCR?